Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2006

Apr 4, 2006

29777_dirs_2006-04-04_e019253e-4376-4211-8fe5-e386dcb7c73b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-04-03

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-04-03 Common shares without par value S 10000 $42.41 Disposed 83675 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 20000 Indirect
Common shares without par value 14851 Indirect
Common shares without par value 858 Indirect

Footnotes

F1: This sale was made pursuant to a previously adopted plan complying with rule 10b5-1(c). The plan was adopted on February 7, 2006.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2006.

F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in a transaction exempt from Section 16 under 16(a)-11.

F5: Reporting person disclaims beneficial ownership of all securities held by his son.